Precipio Inc PRPO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $23.36
- Day Range
- $22.87–23.93
- 52-Week Range
- $9.67–33.63
- Bid/Ask
- $17.57 / $24.50
- Shares Outstanding
- 1.79M
- Market Cap
- $41.99M
- Volume/Avg
- 22,939 / 32,913
Key Statistics
- Price/Earnings (Normalized)
- 88.77
- Price/Sales
- 1.52
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 71
- Website
- https://www.precipiodx.com
Valuation
|
Metric
|
PRPO
|
|---|---|
Price/Earnings (Normalized) | 88.77 |
Price/Book Value | 2.96 |
Price/Sales | 1.52 |
Price/Cash Flow | 12.33 |
Price/Earnings
PRPO
Financial Strength
|
Metric
|
PRPO
|
|---|---|
Quick Ratio | 1.21 |
Current Ratio | 1.56 |
Interest Coverage | −13.63 |
Quick Ratio
PRPO
Profitability
|
Metric
|
PRPO
|
|---|---|
Return on Assets (Normalized) | 1.55% |
Return on Equity (Normalized) | 2.32% |
Return on Invested Capital (Normalized) | 2.27% |
Return on Assets
PRPO
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Zdzvtcmsgp | Vqrdv | $176B | |||
| Danaher Corp
DHR
| Qcxhzkwbn | Pnj | $130B | |||
| IDEXX Laboratories Inc
IDXX
| Mbrhtfryv | Pbzf | $44B | |||
| Agilent Technologies Inc
A
| Mfbfyhznp | Vjx | $38B | |||
| Waters Corp
WAT
| Tdwmsccg | Gnp | $36B | |||
| IQVIA Holdings Inc
IQV
| Rwfccdh | Sgkcnv | $31B | |||
| Illumina Inc
ILMN
| Vpgcwbns | Psmshg | $25B | |||
| Mettler-Toledo International Inc
MTD
| Grhhzmmsh | Qgxjvww | $23B | |||
| Quest Diagnostics Inc
DGX
| Rtgvnys | Ltkln | $22B | |||
| Labcorp Holdings Inc
LH
| Lbpbsyyd | Hvqkdb | $22B |
United States